Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A LAFONTAINE

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
RNA Biology|October 6, 2021
Inactivation of the riboswitch-controlled GMP synthase GuaA in <i>Clostridioides difficile</i> is associated with severe growth defects and poor infectivity in a mouse model of infectionErich Smith-Peter, David Lalonde Séguin, Émilie St-Pierre, et al.
Journal of Medicinal Chemistry|March 3, 2015
Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressureQinhua Huang, Eugene Y Rui, Morena Cobbs, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesityJennifer A Lafontaine, Robert F Day, Joe Dibrino, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsPaul S Humphries, Jennifer A Lafontaine, Charles S Agree, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
RNA Biology|October 6, 2021
Inactivation of the riboswitch-controlled GMP synthase GuaA in <i>Clostridioides difficile</i> is associated with severe growth defects and poor infectivity in a mouse model of infectionErich Smith-Peter, David Lalonde Séguin, Émilie St-Pierre, et al.
Journal of Medicinal Chemistry|March 3, 2015
Design, synthesis, and evaluation of NO-donor containing carbonic anhydrase inhibitors to lower intraocular pressureQinhua Huang, Eugene Y Rui, Morena Cobbs, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2007
Discovery of potent and orally bioavailable heterocycle-based beta3-adrenergic receptor agonists, potential therapeutics for the treatment of obesityJennifer A Lafontaine, Robert F Day, Joe Dibrino, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsPaul S Humphries, Jennifer A Lafontaine, Charles S Agree, et al.
Pageof 11